Cardiac Magnetic Resonance-Verified Myocardial Fibrosis in Chagas Disease: Clinical Correlates and Risk

Marly Uellendahl1,2,3, Maria Eduarda Menezes de Siqueira2,3, Eveline Barros Calado2,3

  • 1Setor de Ressonância Magnética Cardiovascular do Instituto do Coração (InCor) - Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP.

Insights

Cardiac magnetic resonance (CMR) effectively identifies myocardial fibrosis in Chagas disease patients, correlating strongly with the Rassi score for prognostic stratification.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Parasitic Diseases

Background:

  • Chagas disease (CD) is a significant cause of heart failure and mortality, particularly in Latin America.
  • Evaluating cardiac morphology, function, and myocardial fibrosis (MF) is crucial for prognosis.
  • Cardiac magnetic resonance (CMR) offers advanced imaging for assessing these parameters.

Purpose of the Study:

  • To evaluate cardiac morphological and functional characteristics in Chagas disease patients using CMR.
  • To assess the extent of myocardial fibrosis (MF) via myocardial-delayed enhancement (MDE) with CMR.
  • To compare the prognostic value of CMR-detected MF with the Rassi score.

Main Methods:

  • 39 patients with Chagas disease were studied, divided into indeterminate (IND) and Chagas heart disease (CHD) groups.
  • All patients underwent CMR, including cine-MRI and MDE sequences.
  • The extent of MF detected by MDE was quantified and compared with the Rassi score.

Main Results:

  • Significant morphological and functional differences were observed between the IND and CHD groups (p < 0.001).
  • A strong positive correlation was found between the extent of MF and the Rassi score (r = 0.76).

Conclusions:

  • CMR is a valuable tool for evaluating Chagas disease patients across all clinical presentations.
  • The strong correlation between CMR-derived MF and the Rassi score highlights CMR's utility in prognostic stratification.
  • CMR provides detailed insights into cardiac changes and fibrosis extent in Chagas disease.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
702
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
524
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741